Website Search
In a previous post we noted the increasing importance of biologics as therapeutic agents, with 37% of the drugs approved by the FDA in 2017 being biologic entities. A recent article in Chemical & ...
In its short history, the LIMS industry has seen more than a few myths come and go. Most of the time, these myths are the result of misconceptions that are based on misunderstanding. Unfortunately, a laboratory that accepts these myths as fact may be missing out on an opportunity to make a significant improvement in the efficiency of their data management. Let's take a look at the top 5 myths about LIMS interfacing and see if we can find the real truth behind them.
To read the full article, Please click here to login into CambridgeSoft.com
To download a file, right click on the corresponding link and choose "Save Links As" or "Save Target As".